The American Asthma Foundation has announced a research breakthrough suggesting that, contrary to popular belief, drugs commonly used to treat high blood pressure may also bring relief to many asthma sufferers.
Dean Smith, executive director of the AAF, said, "drugs known as beta blockers have long been used to treat high blood pressure. However, they have historically been forbidden for patients with asthma, because they may make the symptoms worse. Now, however, results from a research study funded by the American Asthma Foundation suggest that, over the long run, asthma may well improve with low daily doses of beta blockers."
The findings were published January 26 on www.pnas.org, the on-line edition of Proceedings of the National Academy of Sciences of the USA. The lead investigator, Richard Bond, and his colleagues demonstrated the absence of asthma-like symptoms in laboratory mice that do not have the very receptor that is inhibited by beta blockers. This finding was in agreement with earlier studies by Dr Bond et al showing that low doses of beta blockers improved asthma in mice.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze